南模生物：拟6500万元参投策源一期基金 投资人工智能、航空航天、量子科技、机器人等领域

Core Viewpoint - Nanmo Bio (688265.SH) plans to invest RMB 65 million as a limited partner in the expansion of Shanghai Xinjuzhiyuan Phase I Venture Capital Partnership, increasing the fund size to RMB 432 million, with a contribution ratio of 15.05% [1] Investment Details - The fund will focus on strategic emerging industries, including new materials, artificial intelligence, aerospace, quantum technology, robotics, high-end equipment, and the biopharmaceutical industry [1]